Child ADHD risk linked to mother’s use of acetaminophen
On Feb. 20, 2025, researchers from the University of Washington and Seattle Children’s Research Institute announced findings from…
CPRIT awards $68 million in research grants to Texas institutions
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyager™ DSLT, the first and only…
Parental Alcohol Use Linked To Increased Cancer Risk In Children, Texas A&M Researchers Find
On Feb. 19, 2025, research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences has discovered…
St, Judes Reports Promising results from first prenatal therapy for spinal muscular atrophy
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
Woman in cancer remission for record 19 years after CAR-T immune treatment
On Feb. 17, 2025, researchers from Texas Children’s Hospital in Houston announced that the four year old girl…
Researchers identify DNA changes, biological pathways associated with inherited cancer risk
On Feb. 17, 2025, Stanford researchers have conducted the first large-scale screen of these inherited changes, called single…
Tanzania confirms additional Deaths from Marburg virus disease
On Feb. 14, 2025, the World Health Organization (WHO) announced that a cumulative of two confirmed and eight…
Next-gen Alzheimer’s drugs extend independent living by months
On Feb. 13, 2025, researchers at Washington University School of Medicine in St. Louis announced a new analysis…
Mechanism for treating muscle degeneration discovered
On Feb. 12, 2025, researchers at the Max Planck Institute released a study that could pave the way…
New blood test accurately predicts preeclampsia
On Feb. 12, 2025, a study led by researchers from the University of Washington announced that a new…
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy
On Feb. 12, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved a New…
‘Junk’ RNA segments play role in protein production, cell stress response
On Feb. 11, 2025, scientists from Ohio State University (OSU) have discovered that some tiny segments of RNA…
Novartis acquires Anthos Therapeutics and late-stage cardiovascular pipeline for USD $3.1 billion
On Feb. 11, 2025, Novartis announced an agreement to acquire Anthos Therapeutics, a Boston-based, privately held, clinical-stage biopharmaceutical…
Research shows path to easier diagnosis of mitochondrial disorders
On Feb. 11, 2025, in study of mitochondrial disease at the University of Alberta researcher revealed an easier…
man destined for early Alzheimer’s Survived More Than Twenty Years longer than expected
On Feb. 10, 2025, scientists announced identifying genetic variants that could have helped a man to avoid dementia…
Yale scientists recode the genome for programmable synthetic proteins
On Feb. 6, 2025, a team of synthetic biologists from Yale University announced they have re-written the genetic…
Mutations in two gene pairs point to a promising drug target in 5 percent of adult cancers
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
Scientists Identify Alzheimer’s Disease-Protective Genetic Factors and Unravel Disease Mechanisms
On Feb. 4, 2025, an international research teams led by Hong Kong University of Science and Technology (HKUST)…
Biotechnology | Disease | FDA | Life Science News | Neurology | Ophthalmogy | Therapeutics
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
On Feb. 4, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Susvimo® (ranibizumab…
Groundbreaking Ebola vaccination trial launches in Uganda
On Feb. 3, 2025, in a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and…
TGen researchers create spatial map of gene expression in pulmonary fibrosis
On Feb. 3, 2025, a team of researchers co-led by TGen, part of City of Hope announced creating…
tuberculosis outbreak from 2024 Ongoing in Kansas
On Jan. 31, 2025, the Kansas Department of Health and Environment (KDHE) reported that there were 67 confirmed…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
WHO accelerates efforts to support response to Sudan virus disease outbreak in Uganda
On Jan. 30, 2025, the World Health Organization (WHO) announced it was mobilizing efforts to support national health…
WHO verifies Niger as the first country in the African Region to eliminate onchocerciasis
On Jan. 30, 2025, the World Health Organization (WHO) congratulated Niger for having met the criteria for onchocerciasis…
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
On Jan. 30, 2025, the U.S. Food and Drug Administration (FDA) approved Vertex Pharmaceuticals’s Journavx (suzetrigine) 50 milligram…
‘Breakthrough’ stem-cell patches strengthened a woman’s failing heart
On Jan. 29, 2025, researchers from the University Medical Center Göttingen announced they have shown that patches of…
University of Queensland team finds relative of deadly Hendra virus in the U.S.
On Jan. 29, 2025, researchers at The University of Queensland announced they have identified the first henipavirus in…
Mapping of a gigantic salamander genome reveals secrets of regeneration
Jan. 29, 2025, an international team of researchers led by the Karolinska Institutet announced they have mapped the…